Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection
Masashi Takenaka, Vijay Subramanian, Venkataswarup Tiriveedhi, Donna Phelan, Ramsey Hachem, Elbert Trulock, Andrew E. Gelman, G. Alexander Patterson, Kiyotaka Hoshinaga, Thalachallour Mohanakumar
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection'. Together they form a unique fingerprint.